Akademisyen
MUSLİH ÜRÜN
DOÇENT
VAN YÜZÜNCÜ YIL ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Tıbbi Onkoloji (İç Hastalıkları)
Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.
- Makale 42
- Proje 0
- Kitap 0
- Bildiri 0
- Patent 0
- Sanatsal 0
Scopus (SJR)
Q1
12
Q2
21
Q3
3
Q4
6
WoS (JCR)
Q1
13
Q2
11
Q3
8
Q4
4
TR Index
29
makale
Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.
Üst %1 makale
0
Üst %10 makale
6
Ort. yüzdelik
45.1%
Üst %1 payı
0.0%
Üst %10 payı
9.0%
Makaleler
YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.
Makale listesi
- 2026 Does the Duration of FLOT Infusion Change the Outcome of Perioperative Treatment for Gastric Cancer? Comparing 24- and 48-h Infusions YÖKSİS SJR Q2 JCR Q1 OpenAlex 54.0%
- 2026 Baseline vitamin D status and clinical outcomes in advanced non-small cell lung cancer patients treated with nivolumab. YÖKSİS SJR Q1 JCR Q1 OpenAlex 33.2%
- 2026 Prognostic Significance of C-PLAN Index in Patients Treated with Immunotherapy for Non-Small-Cell Lung Cancer YÖKSİS SJR Q2 JCR Q1 OpenAlex 3.1%
- 2026 Evaluation of inflammatory parameters and ferritin as prognostic factors in non-small cell lung cancer patients receiving nivolumab immunotherapy Prognostic inflammatory biomarkers in NSCLC immunotherapy YÖKSİS SJR Q2 JCR Q3 OpenAlex üst %10 OpenAlex 95.9%
- 2026 Bone Metastasis Distribution Matters: Prognostic Effect of the Axial-to-Peripheral Ratio in Metastatic Hormone-Sensitive Prostate Cancer YÖKSİS SJR Q1 JCR Q2 OpenAlex 31.0%
- 2026 Real-World Treatment Outcomes After Nivolumab Progression in BRAF-Negative Metastatic Melanoma: A Multicenter Cohort Study by the Turkish Oncology Group YÖKSİS SJR Q2 JCR Q1 OpenAlex 61.7%
- 2026 Prognostic Effect of KELIM Score of Prostate-Specific Antigen in Hormone-Sensitive Prostate Cancer Patients Treated With Novel Androgen Receptor Inhibitors: Pioneering New Ways YÖKSİS SJR Q1 JCR Q2 OpenAlex 40.3%
- 2026 Impact of renin-angiotensin system inhibitors on the clinical outcomes of nivolumab therapy in metastatic non-small cell lung cancer YÖKSİS SJR Q2 JCR Q3 OpenAlex üst %10 OpenAlex 95.7%
- 2025 Prognostic value of IMDC score in non-small cell lung cancer receiving immunotherapy: old dog, new tricks? YÖKSİS SJR Q2 JCR Q2 OpenAlex 58.0%
- 2025 Health-related quality of life and psychosocial outcomes in long-term survivors treated with immune checkpoint inhibitors: a nationwide multicenter study YÖKSİS OpenAlex 79.2%
- 2025 Response: Do Nutritional and Inflammatory Indices Predict Response in Geriatric Gastric Cancer Patients Treated With Neoadjuvant FLOT Regimen? YÖKSİS SJR Q1 JCR Q2 OpenAlex 17.4%
- 2025 A comparative analysis of the efficacy and safety of cisplatin and oxaliplatin-based chemotherapy regimens in elderly patients with metastatic gastric cancer. YÖKSİS TR Index SJR Q4 OpenAlex 64.7%
- 2025 Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer YÖKSİS OpenAlex üst %10 OpenAlex 92.7%
- 2025 Do Nutritional and Inflammatory Indices Predict Response in Geriatric Gastric Cancer Patients Treated with Neoadjuvant FLOT Regimen? YÖKSİS SJR Q1 JCR Q2 OpenAlex 86.0%
- 2025 Vincamine Mitigates Methotrexate-Induced Liver Fibrosis Model YÖKSİS TR Index SJR Q3 JCR Q3 OpenAlex 27.6%
- 2025 Evaluation of second-line treatment options in metastatic esophageal squamous cell carcinoma YÖKSİS TR Index OpenAlex 13.0%
- 2025 Comparison of Doublet and Triplet Chemotherapy Regimens in Geriatric Patients with Metastatic Gastric Cancer YÖKSİS TR Index OpenAlex 21.9%
- 2025 The Role Of Biomarkers In Predicting Neoadjuvant Treatment Response In Gastric Cancer YÖKSİS TR Index SJR Q4 OpenAlex 68.0%
- 2024 BEFORE & AFTER: THE EVALUATION OF THE EFFECT OF THE COVID-19 PANDEMIC ON CANCER PATIENTS IN PALLIATIVE CARE CENTER YÖKSİS OpenAlex 14.0%
- 2024 Positive Lymph Node Ratio as a new prognostic score in Geriatric patients with operated gastric cancer YÖKSİS SJR Q1 JCR Q1 OpenAlex 59.2%